T9G (T9G) News
Follow T9G (T9G) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 13 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Vidac Pharma Holding PLC: Results of Annual General Meeting
Shareholders approved the reappointment of Dr. Max Herzberg, Mr. Yochai Richter, Dr. Christian Policard and Mr. Joseph Tenne as directors. The meeting received the Company's annual report and other items.
EQUITY | Oct 04, 2026, 08:35 AM UTC
L
Vidac Pharma Holding PLC (T9G) Releases Unaudited H1 2026 Interim Financials
Vidac Pharma Holding PLC published its unaudited condensed consolidated interim financial statements for the six months ended 30 June 2026.Material DetailsContext by AI AnalystThis is a routine financial update for a cli
NEWS | Sep 29, 2026, 01:02 PM UTC
L
Vidac Pharma Publishes Unaudited Interim Financial Statements for the First Half of 2026
Vidac Pharma Holding PLCby Sandra GamzonBusiness news for the stock marketVidac Pharma Holding PLC: Vidac Pharma Publishes Unaudited Interim Financial Statements for the First Half of 2026London (pta000/29.09.2026/15:00
EQUITY | Sep 29, 2026, 01:01 PM UTC
L
Vidac Pharma Holding PLC (T9G) Posts Unaudited H1 2026 Interim Results
Vidac Pharma Holding PLC published its unaudited condensed consolidated interim financial statements for the six months ended 30 June 2026.Material DetailsContext by AI AnalystThis is a routine interim update for a clini
NEWS | Sep 29, 2026, 01:01 PM UTC
L
PTA-News: Vidac Pharma Holding PLC: Vidac Pharma Publishes Unaudited Interim Financial Statements for the First Half of 2026
Vidac Pharma Holding PLCby Sandra GamzonBusiness news for the stock market London (pta/29.09.2026/15:00) - Vidac Pharma Holding PLC announces the publication of its Unaudited Condensed Consolidated Interim Financial Stat
EQUITY | Sep 29, 2026, 01:01 PM UTC
L
Vidac Pharma Holding PLC (XETR:T9G) Completes Last Visit in Phase 2b AK Trial
Vidac Pharma Holding PLC reached last patient last visit in its randomized, double-blind, placebo-controlled Phase 2b study of topical VDA-1102 in highly proliferative actinic keratosis. No treatment-related serious adve
NEWS | Sep 15, 2026, 06:41 AM UTC
L
Vidac Pharma Holdings Plc. Hits LPLV in Phase 2b AK Trial; Data Analysis Next
Vidac Pharma completed the last patient's last visit in its randomized, double-blind, placebo-controlled Phase 2b study of topical VDA-1102 in highly proliferative actinic keratosis. Final data review is underway; result
NEWS | Sep 15, 2026, 06:41 AM UTC
L
Reaches Last Patient Last Visit in Phase 2b Study of VDA-1102 in Actinic Keratosis
Vidac Pharma Holding PLCby Sandra GamzonBusiness news for the stock marketVidac Pharma Holding PLC: Reaches Last Patient Last Visit in Phase 2b Study of VDA-1102 in Actinic KeratosisCompletion of patient follow-up marks
EQUITY | Sep 15, 2026, 06:40 AM UTC
L
PTA-News: Vidac Pharma Holding PLC: Reaches Last Patient Last Visit in Phase 2b Study of VDA-1102 in Actinic Keratosis
Vidac Pharma Holding PLCby Sandra GamzonBusiness news for the stock market London (pta/15.09.2026/08:40) - Vidac Pharma Holdings Plc., a clinical-stage biopharmaceutical company developing first-in-class therapies target
EQUITY | Sep 15, 2026, 06:40 AM UTC
L
Vidac Pharma Holding PLC issues notice of annual general meeting
Vidac Pharma Holding PLC has published a notice for its annual general meeting.
EQUITY | Sep 08, 2026, 05:35 PM UTC
L
Vidac Pharma Holding issues notice for annual general meeting
Vidac Pharma Holding PLC published a Notice of Annual General Meeting. The notice was dated London (19:35 UTC+2) as carried by TradingView News.
EQUITY | Sep 08, 2026, 05:35 PM UTC
L
Vidac Pharma Holding publishes 2025 annual report and financial statements
Vidac Pharma Holding PLC has published its 2025 annual report and financial statements.
EQUITY | Aug 31, 2026, 06:30 AM UTC
L
Unresolved publishes 2025 annual report and financial statements
Unresolved publishes its 2025 Annual Report and Financial Statements.
EQUITY | Aug 31, 2026, 06:30 AM UTC